Osteomalacia: Causes, Symptoms, Diagnosis & Treatment

Osteomalacia is a metabolic bone disorder in adults where bone mineralization fails, causing soft, weak bones prone to pain, fractures, and deformities. Vitamin D deficiency is the most common cause, but issues with calcium, phosphate, or underlying diseases also contribute. Symptoms include bone pain, muscle weakness, and fatigue. Diagnosis involves lab tests (low vitamin D, high alkaline phosphatase) and imaging. Treatment focuses on vitamin D, calcium, and phosphate replacement, along with managing underlying causes. Early detection improves outcomes.

Osteomalacia is a metabolic bone disorder characterized by defective mineralization of mature bone matrix (osteoid) after the closure of growth plates. The condition results in soft, weak bones that are more susceptible to pain, deformities, and fractures.

Although vitamin D deficiency remains the most common cause of osteomalacia worldwide, several other disorders affecting calcium, phosphate, or vitamin D metabolism may also contribute to its development. Osteomalacia is often underdiagnosed because its symptoms can be subtle and nonspecific during the early stages.

This article reviews the pathophysiology, causes, clinical manifestations, diagnosis, treatment, and prevention of osteomalacia based on current medical evidence.

What is Osteomalacia?

Osteomalacia refers to inadequate mineralization of the bone matrix in adults. In children, a similar mineralization defect affects the growth plates and is known as rickets.

Normal bone mineralization requires adequate levels of:

Vitamin D
Calcium
Phosphate
Functional osteoblast activity

When these factors are disrupted, newly formed osteoid fails to mineralize properly, resulting in soft and fragile bones.

See Also: Bone Formation

Osteomalacia Causes, Symptoms, Diagnosis, Treatment, and Prevention

Epidemiology

Osteomalacia remains a significant global health concern despite advances in nutritional awareness.

Individuals at increased risk include:

Elderly adults
Institutionalized patients
Individuals with limited sunlight exposure
Patients with malabsorption syndromes
Chronic kidney disease patients
Chronic liver disease patients
Individuals taking anticonvulsant medications
People with poor dietary vitamin D intake

Vitamin D deficiency remains the leading cause of osteomalacia worldwide.

Pathophysiology of Osteomalacia

Bone strength depends on proper mineralization of the collagen-rich osteoid matrix.

In osteomalacia:

Vitamin D deficiency reduces intestinal calcium absorption.
Hypocalcemia stimulates parathyroid hormone (PTH) secretion.
Secondary hyperparathyroidism increases phosphate loss through the kidneys.
Reduced calcium and phosphate availability impairs hydroxyapatite formation.
Osteoid accumulates without adequate mineralization.

The result is a soft skeleton prone to fractures and deformities.

Causes of Osteomalacia

Vitamin D Deficiency

The most common cause of osteomalacia.

Causes include:

Inadequate sunlight exposure
Dark skin pigmentation
Excessive sunscreen use
Poor dietary intake
Aging-related reduction in cutaneous vitamin D synthesis

Malabsorption Syndromes

Several gastrointestinal disorders reduce vitamin D absorption:

Celiac disease
Crohn disease
Chronic pancreatitis
Short bowel syndrome
Bariatric surgery

Chronic Kidney Disease

The kidneys convert 25-hydroxyvitamin D into active 1,25-dihydroxyvitamin D (calcitriol). Impaired renal function reduces active vitamin D production.

Chronic Liver Disease

The liver is responsible for vitamin D hydroxylation. Liver dysfunction can impair vitamin D metabolism.

Hypophosphatemic Disorders

Low serum phosphate levels may cause defective bone mineralization.

Examples include:

X-linked hypophosphatemia
Tumor-induced osteomalacia
Fanconi syndrome

Medications

Several drugs may contribute to osteomalacia:

Phenytoin
Phenobarbital
Carbamazepine
Rifampin
Long-term aluminum-containing antacids

Risk Factors

Common risk factors include:

Advanced age
Institutionalization
Limited outdoor activity
Veiled clothing practices
Obesity
Malnutrition
Chronic kidney disease
Gastrointestinal disorders
Long-term anticonvulsant therapy

Symptoms of Osteomalacia

Symptoms often develop gradually and may be overlooked.

Common clinical manifestations include:

Bone Pain

Diffuse skeletal pain is one of the hallmark symptoms.

Frequently affected areas:

Lower back
Hips
Pelvis
Ribs
Lower extremities

Muscle Weakness

Proximal muscle weakness commonly affects:

Thigh muscles
Shoulder girdle muscles

Patients may report:

Difficulty climbing stairs
Difficulty standing from a seated position
Difficulty walking

Fatigue

Generalized weakness and chronic fatigue are common complaints.

Fragility Fractures

Softened bones are more susceptible to:

Stress fractures
Insufficiency fractures
Pseudofractures (Looser zones)

Physical Examination Findings

Healthcare providers may observe:

Antalgic gait
Waddling gait
Proximal muscle weakness
Bone tenderness
Skeletal deformities in advanced disease

Diagnosis of Osteomalacia

Diagnosis requires a combination of clinical assessment, laboratory testing and imaging studies.

Laboratory Findings

Typical biochemical abnormalities include:

Laboratory Test	Typical Finding
25-Hydroxyvitamin D	Low
Calcium	Low or normal
Phosphate	Low
Alkaline Phosphatase	Elevated
Parathyroid Hormone (PTH)	Elevated
1,25-Dihydroxyvitamin D	Variable

Elevated alkaline phosphatase is one of the most important biochemical markers.

Imaging Studies

Plain Radiographs

X-rays may demonstrate:

Generalized osteopenia
Cortical thinning
Looser zones (pseudofractures)

Common sites include:

Femoral neck
Pubic rami
Scapula
Ribs

Bone Mineral Density (DEXA)

DEXA scanning may reveal reduced bone density but cannot distinguish osteomalacia from osteoporosis.

Bone Biopsy

Bone histomorphometry remains the definitive diagnostic test but is rarely required in routine clinical practice.

Differential Diagnosis

Conditions that may mimic osteomalacia include:

Osteoporosis
Multiple myeloma
Metastatic bone disease
Hyperparathyroidism
Renal osteodystrophy
Fibromyalgia

Accurate laboratory assessment is critical for differentiation.

Treatment of Osteomalacia

Treatment focuses on correcting the underlying cause and restoring normal mineralization.

Vitamin D Replacement

For vitamin D deficiency-related osteomalacia, supplementation is the cornerstone of therapy.

Common regimens include:

Cholecalciferol (Vitamin D3)
Ergocalciferol (Vitamin D2)

Severe deficiency may require:

50,000 IU weekly for 8–12 weeks
Maintenance therapy of 800–2000 IU daily

Treatment should be individualized according to laboratory findings and patient characteristics.

Calcium Supplementation

Adequate calcium intake is necessary for effective treatment.

Recommended intake generally ranges around:

1000–1200 mg daily

Dietary sources include:

Dairy products
Fortified foods
Leafy green vegetables

Phosphate Replacement

Patients with hypophosphatemic osteomalacia may require:

Oral phosphate supplementation
Active vitamin D analogs

Management of Underlying Disorders

Successful treatment often requires addressing contributing conditions such as:

Malabsorption syndromes
Chronic kidney disease
Chronic liver disease
Tumor-induced osteomalacia

Monitoring Response to Therapy

Monitoring typically includes:

Serum calcium
Serum phosphate
Alkaline phosphatase
Parathyroid hormone
25-hydroxyvitamin D levels

Clinical improvement often occurs within weeks, while complete skeletal recovery may take several months.

Complications of Untreated Osteomalacia

Failure to treat osteomalacia may result in:

Chronic pain
Progressive muscle weakness
Fragility fractures
Skeletal deformities
Reduced mobility
Increased fall risk

Prevention of Osteomalacia

Preventive measures include:

Adequate Vitamin D Intake

Adults should maintain sufficient vitamin D intake through:

Diet
Supplements when indicated

Safe Sun Exposure

Regular sunlight exposure supports endogenous vitamin D production.

Adequate Calcium Consumption

Balanced dietary calcium intake is essential for bone health.

Screening High-Risk Populations

Early detection is recommended for:

Older adults
Patients with malabsorption
Chronic kidney disease patients
Long-term anticonvulsant users

Osteomalacia vs Osteoporosis

Feature	Osteomalacia	Osteoporosis
Primary Defect	Poor mineralization	Reduced bone mass
Bone Quality	Soft bones	Fragile bones
Vitamin D Deficiency	Common	May coexist
Alkaline Phosphatase	Elevated	Usually normal
Treatment	Correct mineral deficiency	Antiresorptive/anabolic therapy

Prognosis

The prognosis of osteomalacia is generally excellent when diagnosed early and treated appropriately.

Most patients experience:

Reduced bone pain
Improved muscle strength
Enhanced mobility
Decreased fracture risk

Delayed diagnosis may result in irreversible skeletal deformities and prolonged disability.

Key Takeaways

Osteomalacia is a disorder of defective bone mineralization in adults.
Vitamin D deficiency is the most common cause worldwide.
Symptoms include bone pain, muscle weakness, fatigue, and fractures.
Laboratory findings typically show low vitamin D, elevated alkaline phosphatase, and secondary hyperparathyroidism.
Treatment focuses on vitamin D, calcium, phosphate replacement, and management of underlying causes.
Early diagnosis significantly improves outcomes and prevents complications.

References & More

Zimmerman L, Anastasopoulou C, McKeon B. Osteomalacia. [Updated 2024 Sep 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551616/
Zimmerman L, Anastasopoulou C, McKeon B. Osteomalacia. 2024 Sep 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 31869080. Pubmed